What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
Immunology, Immune system, Internal medicine, Cancer and Antigen are his primary areas of study.
His biological study spans a wide range of topics, including Cytotoxic T cell, Lung cancer, Human leukocyte antigen and Protocol.
His research investigates the connection between Cytotoxic T cell and topics such as Epitope that intersect with issues in Ipilimumab.
His work carried out in the field of Ipilimumab brings together such families of science as Pembrolizumab, Nivolumab and Talimogene laherparepvec.
His research in Internal medicine intersects with topics in Placebo, Surgery and Oncology.
His Surgery study frequently draws connections to other fields, such as Melanoma.
His most cited work include:
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma. (10003 citations)
- Cancer classification using the Immunoscore: a worldwide task force (525 citations)
- Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution (420 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Immunology, Oncology, Immune system and Cancer research.
He combines subjects such as Surgery, Placebo and Melanoma with his study of Internal medicine.
Christian H. Ottensmeier has researched Melanoma in several fields, including Gastroenterology and Clinical trial.
His work deals with themes such as Cancer and Cytotoxic T cell, which intersect with Immunology.
His Oncology research includes elements of Carboplatin, Nivolumab, Phases of clinical research and Pathology.
His Cancer research study combines topics in areas such as Lung cancer and Downregulation and upregulation.
He most often published in these fields:
- Internal medicine (38.28%)
- Immunology (39.66%)
- Oncology (31.38%)
What were the highlights of his more recent work (between 2019-2021)?
- Immune system (29.31%)
- Immunology (39.66%)
- Transcriptome (12.07%)
In recent papers he was focusing on the following fields of study:
Christian H. Ottensmeier spends much of his time researching Immune system, Immunology, Transcriptome, Cytotoxic T cell and Gene expression.
His Immune system research includes themes of Cancer research, Antibody, Disease and Cell type.
Immunology is closely attributed to Melanoma in his study.
His Transcriptome study incorporates themes from Chemokine and CD8.
He focuses mostly in the field of Adjuvant, narrowing it down to matters related to Bevacizumab and, in some cases, Oncology.
His research integrates issues of Lymphocyte and NY-ESO-1 in his study of Oncology.
Between 2019 and 2021, his most popular works were:
- Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4 + T Cells in COVID-19. (49 citations)
- Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4 + T Cells in COVID-19. (49 citations)
- Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4 + T Cells in COVID-19. (49 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
Christian H. Ottensmeier mostly deals with Cytotoxic T cell, Immune system, Transcriptome, Gene expression and Severe acute respiratory syndrome coronavirus 2.
His study focuses on the intersection of Cytotoxic T cell and fields such as CD8 with connections in the field of Glycolysis, T cell, Virus, Respiratory system and Cytotoxicity.
His research is interdisciplinary, bridging the disciplines of Cancer research and Immune system.
Many of his studies on Transcriptome involve topics that are commonly interrelated, such as Immunology.
His biological study deals with issues like Disease, which deal with fields such as Apoptosis.
He usually deals with Gene expression and limits it to topics linked to Chemokine and Molecular biology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
